Abstract
Objective of this article is to appraise diagnostic aspects and treatment modalities in childhood ovarian tumor in background of available evidence. Literature search on Pubmed revealed various aspects of epidemiology, histopathological diagnosis, and treatment of pediatric ovarian tumor. 85 % of childhood tumors are germ cell tumors. The varied histopathological picture in germ cell tumors poses a diagnostic and therapeutic challenge. Immunohistochemistry and newer genetic markers like SALL4 and karyopherin-2 (KPNA2) have been helpful in differentiating ovarian yolk sac tumor from dysgerminoma, teratomas, and other pictures of hepatoid, endometrioid, clear cell carcinomatous, and adenocarcinomatous tissues with varied malignant potential. Before platinum therapy, these tumors were almost fatal in children. Fertility-conserving surgery with bleomycin, etoposide, and cisplatin has dramatically changed the survival rates in these patients. This modality gives cancer cure with healthy offspring to female patients with childhood ovarian tumor. Evidence also supports this protocol resulting in successful pregnancy rates and safety of cytotoxic drugs in children born to these patients.
Similar content being viewed by others
References
Ximing J Yang,Liang Cheng.Yolk sac Tumor Pathology. e medicine, medscape.com/article/1612196-Overview. 4 Jun 2012.
He L, Ding H, Ding H, et al. Overexpression of Karyopherin 2 in human ovarian malignant germ cell tumor correlates with poor prognosis. PLoS One. 2012;7(9):e42992. doi:10.1371/journalpone.0042992 Epub 2012 Sep 4.
Cao D, Humphrey PA, Allan RW. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer. 2009;115(12):2640–51. doi:10.1002/cncr.24308.
Loh AH, Ong CL, Lam SL, et al. Pediatric risk of malignancy index for preoperative evaluation of childhood ovarian tumor. Pediatr Surg Int. 2012;28:259–66.
Wiltshaw E, Suart-Harris R, Barker GH, et al. Chemotherapy of endodermal sinus tumor(yolk sac tumor) of the ovary: preliminary communication. J R Soc Med. 1982;75(11):888–92.
Curtin JP, Rubin SC, Hoskins WJ, et al. Second-look laparotomy in endodermal sinus tumor: a report of two patients with normal levels of alpha -fetoprotein and residual tumor at reexploration. Obstet Gynecol. 1989;73(5 Pt 2):893–5.
Lian L, Huang H, Huang R, et al. Management of ovarian endodermal sinus tumor. Chin Med J (Engl). 1996;109(5):344–8.
Shen K, Huang R, Lang J. Diagnosis and treatment of endodermal sinus tumor of the vagina. Zhonghua Fu Chan Ke Za Zhi.1999 Feb;34(2):105-7.[Article in Chinese] Source-Chinese Academy of Medical Science, Peking Union Medical College, Peking Union Medical College Hospital, Beijing 100730.
Terenziani M, Spreafico F, Collini P, et al. Endodermal sinus tumor of the vagina. Pediatr Blood Cancer. 2007;48(5):577–8.
Nawa A, Obata N, Kikkawa F, et al. Prognostic factors of patients with yolk sac tumors of the ovary. Am J Obstet Gynecol. 2001;184(6):1182–8.
Metwalley KA, Elsers DA, Farghaly HS, et al. Precocious puberty secondary to a mixed germ cell-sex cord-stromal tumor associated with an ovarian yolk sac tumor: a case report. J Med Case Rep. 2012;6(1):162.
Cicin I, Saip P, Guney N, et al. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors. Eur J Obstet Gynecol Reprod Biol. 2009;146(2):210–4 Epub 2009 May 5.
Kang H, Kim TJ, Kim WY, et al. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Gynecol Oncol. 2008;111(1):106–10 Epub 2008 Jul 25.
de La Motte Rouge T, Pautier P, Rey A. Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases. Eur J Cancer. 2011;47(2):175–82. doi:10.1016/j.ejca.2010.08.012 Epub 2010 Sep 28.
Tao T, Yang J, Cao D, et al. Conservative treatment and long-term follow up of endodermal sinus tumor of the vagina. Gynecol Oncol. 2012;125(2):358–61.
Zhang R, Sun YC, Zhang GY, et al. Treatment of malignant ovarian germ cell tumors and preservation of fertility. Eur J Gynaecol Oncol. 2012;33(5):489–92.
Anita AN, Rushdan MN. Reproductive function after treatment of ovarian germ cell malignancy. Med J Malays. 2012;67(1):71–6.
Chang YW, Chao KC, Sung PL. Treatment of ovarian endodermal sinus tumor to preserve fertility. J Chin Med Assoc. 2013;76(2):112–4. doi:10.1016/j.jcma.2012.09.011 Epub 2012 Dec 28.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mahadik, K., Ghorpade, K. Childhood Ovarian Malignancy. J Obstet Gynecol India 64, 91–94 (2014). https://doi.org/10.1007/s13224-014-0533-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13224-014-0533-4